Financial statements Bioproten
Cash flow statement of Bioproten
Company age:
Age:
7 y. 8 m. 12 d.
Share capital:
Share capital:
2 855 100 PLN
Cash inflows of BIOPROTEN
|
Year
|
2018
|
2019
|
2020
|
2022
|
|---|---|---|---|---|
| Net cash from operating expenses | - | 7 516 111,53 | 22 300 806,12 | 10 726 804,56 |
| Net cash flow from investing activities | - | -2 457 395,61 | -13 209 665,03 | -1 671 226,82 |
| Net cash flow from financial activities | - | -5 543 647,29 | -6 975 558,45 | -8 376 237,96 |
| Total net cash flow | - | -484 931,37 | 2 115 582,64 | 679 339,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.